Affiliations 

  • 1 Department of Biotechnology Engineering, College of Engineering, International Islamic University Malaysia, Kuala Lumpur 50728, Malaysia
  • 2 Department of Biotechnology Engineering, College of Engineering, International Islamic University Malaysia, Kuala Lumpur 50728, Malaysia; Department of Medical Analysis, Health and Medical Technical College, Baghdad 10047, Iraq
  • 3 Department of Chemistry, College of Sciences for Women, University of Baghdad 10071, Iraq
  • 4 Department of Urology, Hospital Tengku Ampuan Afzan, Kuantan 25200, Malaysia
  • 5 Department of Pathology, Hospital Tengku Ampuan Afzan, Kuantan 25200, Malaysia
Biomed Environ Sci, 2015 Sep;28(9):660-5.
PMID: 26464253 DOI: 10.3967/bes2015.092

Abstract

OBJECTIVE: Nephrolithiasis is one of the most common disorders of the urinary tract. The aim of this study was to examine a possible relationship between DNase I/II activity and E3 SUMO-protein ligase NSE2 in the sera of nephrolithiasis patients to evaluate the possibility of a new biomarker for evaluating kidney damage.
METHODS: Sixty nephrolithiasis patients and 50 control patients were enrolled in a case-control study. Their blood urea, creatinine, protein levels and DNase I/II activity levels were measured by spectrometry. Serum NSMCE2 levels were measured by ELISA. Blood was collected from patients of the government health clinics in Kuantan-Pahang and fulfilled the inclusion criteria.
RESULTS: The result indicated that mean levels of sera NSMCE2 have a significantly increase (P<0.01) in patients compared to control group. Compared with control subjects, activities and specific activities of serum DNase I and II were significantly elevated in nephrolithiasis patients (P$lt;0.01).
CONCLUSION: This study suggests that an increase in serum concentrations of DNase I/II and E3 SUMO-protein ligase NSE2 level can be used as indicators for the diagnosis of kidney injury in patients with nephrolithiasis.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.